Skip to main content
CriticalFDAfda-F-0744-2024LISTERIA

Herold's Salads - Cheddar Mac & Sour Cream packaged in 12oz, 1lb, 2lb, and 5lb plastic containers

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (listeria). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
254
Recall Date
December 7, 2023
Issuing Agency
Hazard
Listeria

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0744-2024.

Potential contamination with Listeria monocytogenes

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0744-2024.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Herold Salads, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0744-2024.

Herold Salads, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Herold Salads, Inc. Recall FAQ

Herold Salads, Inc. is the subject of a dairy safety report: Herold's Salads - Cheddar Mac & Sour Cream packaged in 12oz, 1lb, 2lb, and 5lb plastic containers. The notice was published on December 7, 2023 by the U.S. Food and Drug Administration (FDA). Approximately 254 units are potentially affected.